Skip to main content
Thank you for visiting nature.com. You are using a browser version
with limited support for CSS. To obtain the best experience, we
recommend you use a more up to date browser (or turn off
compatibility mode in Internet Explorer). In the meantime, to
ensure continued support, we are displaying the site without styles
and JavaScript.
Advertisement
[image]
[image]
•  View all journals
•  
Search
•  Log in
•  Content Explore content
•  About the journal
•  Publish with us
•  Subscribe
•  Sign up for alerts
•  RSS feed
1. nature 
2. nature reviews immunology 
3. review articles 
4. article
Show authors
•  Review Article
•  Published: 04 March 2020


Defining trained immunity and
its role in health and disease
•  Mihai G. Netea
  ORCID:
orcid.org/0000-0003-2421-60521,2,3,
•  Jorge Domínguez-Andrés1,2,
•  Luis B. Barreiro4,5,6,
•  Triantafyllos Chavakis7,8,
•  Maziar Divangahi9,10,11,
•  Elaine Fuchs12,
•  Leo A. B. Joosten1,2,
•  Jos W. M. van der Meer1,2,
•  Musa M. Mhlanga13,14,
•  Willem J. M. Mulder15,16,17,
•  Niels P. Riksen1,2,
•  Andreas Schlitzer18,
•  Joachim L. Schultze3,
•  Christine Stabell Benn19,
•  Joseph C. Sun20,21,22,
•  Ramnik J. Xavier23,24 &
•  …
•  Eicke Latz
25,26,27 
Nature Reviews Immunology volume 20, pages 375–388 (2020)Cite
this article
•  196k Accesses
•  2102 Citations
•  948 Altmetric
•  Metrics details
Subjects
•  Immunotherapy
•  Infection


•  SARS-CoV-2
•  Vaccines
Abstract
Immune memory is a defining feature of the acquired immune
system, but activation of the innate immune system can also result
in enhanced responsiveness to subsequent triggers. This process has
been termed ‘trained immunity’, a de facto innate immune memory.
Research in the past decade has pointed to the broad benefits of
trained immunity for host defence but has also suggested
potentially detrimental outcomes in immune-mediated and chronic
inflammatory diseases. Here we define ‘trained immunity’ as a
biological process and discuss the innate stimuli and the epigenetic
and metabolic reprogramming events that shape the induction of
trained immunity.
 Access through your institution
Buy or subscribe
This is a preview of subscription content, access via your institution
Access options
 Access through your institution
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Learn more
Subscribe to this journal


Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Learn more
Buy this article
•  Purchase on SpringerLink
•  Instant access to full article PDF
Buy now
Prices may be subject to local taxes which are calculated during
checkout
Additional access options:
•  Log in
•  Learn about institutional subscriptions
•  Read our FAQs
•  Contact customer support
Fig. 1: Trained immunity and tolerance: two opposite
functional programmes of innate immunity.
[image]
Fig. 2: Central and peripheral trained immunity.
[image]
Fig. 3: Interplay between epigenetics and metabolism.
[image]
Fig. 4: Epigenetic reprogramming underlies the induction of
trained immunity.
[image]
Similar content being viewed by others
[image]


Trained immunity: induction of an inflammatory
memory in disease
Article Open access 14 October 2025
[image]
Trained immunity in type 2 immune responses
Article Open access 05 September 2022
[image]
Trained immunity induced by DAMPs and LAMPs in
chronic inflammatory diseases
Article Open access 01 October 2025
References
1. Medzhitov, R. & Janeway, C. Innate immune recognition:
mechanisms and pathways. Immunol. Rev. 173, 89–97 (2000).
Article  CAS  PubMed  Google Scholar 
2. Lanier, L. L. NK cell recognition. Annu. Rev. Immunol. 23,
225–274 (2005).
Article  CAS  PubMed  Google Scholar 
3. Bonilla, F. A. & Oettgen, H. C. Adaptive immunity. J. Allergy
Clin. Immunol. 125, S33–S40 (2010).
Article  PubMed  Google Scholar 
4. Bowdish, D. M. E., Loffredo, M. S., Mukhopadhyay, S.,
Mantovani, A. & Gordon, S. Macrophage receptors implicated
in the “adaptive” form of innate immunity. Microbes Infect. 9,
1680–1687 (2007).
Article  CAS  PubMed  Google Scholar 


5. Netea, M. G., Quintin, J. & Van Der Meer, J. W. M. Trained
immunity: a memory for innate host defense. Cell Host
Microbe 9, 355–361 (2011). This article describes the
memory features of the innate immune system and
proposes the term ‘trained immunity’ for the first time.
Article  CAS  PubMed  Google Scholar 
6. Naik, S. et al. Inflammatory memory sensitizes skin epithelial
stem cells to tissue damage. Nature 550, 475–480 (2017).
This study shows that epithelial stem cells maintain
chromosomal accessibility at key stress response genes
that are activated by the primary stimulus.
Article  CAS  PubMed  PubMed Central  Google Scholar 
7. Lay, K. et al. Stem cells repurpose proliferation to contain a
breach in their niche barrier. eLife 7, e41661 (2018).
Article  PubMed  PubMed Central  Google Scholar 
8. Christ, A. et al. Western diet triggers NLRP3-dependent innate
immune reprogramming. Cell 172, 162–175 (2018). This
study found that a high-fat diet induces long-lasting
functional reprogramming of immunity in myeloid cells
that remains after mice are returned to a chow diet.
Article  CAS  PubMed  PubMed Central  Google Scholar 
9. Kurtz, J. Specific memory within innate immune systems.
Trends Immunol. 26, 186–192 (2005).
Article  CAS  PubMed  Google Scholar 
10. Conrath, U., Beckers, G. J. M., Langenbach, C. J. G. &
Jaskiewicz, M. R. Priming for enhanced defense. Annu. Rev.
Phytopathol. 53, 97–119 (2015).
Article  CAS  PubMed  Google Scholar 
11. Gourbal, B. et al. Innate immune memory: an evolutionary
perspective. Immunol. Rev. 283, 21–40 (2018).


Article  CAS  PubMed  Google Scholar 
12. Netea, M. G. et al. Trained immunity: a program of innate
immune memory in health and disease. Science 352, aaf1098
(2016).
Article  PubMed  PubMed Central  CAS  Google Scholar 
13. Novakovic, B. et al. β-glucan reverses the epigenetic state of
lps-induced immunological tolerance. Cell 167, 1354–
1368.e14 (2016). This study details the epigenetic and
transcriptional landscape of human macrophage LPS-
induced tolerance and characterizes the potential of β-
glucan to reverse it.
Article  CAS  PubMed  PubMed Central  Google Scholar 
14. Nankabirwa, V. et al. Child survival and BCG vaccination: a
community based prospective cohort study in Uganda. BMC
Public Health 15, 175 (2015).
Article  PubMed  PubMed Central  Google Scholar 
15. Dominguez-Andres, J. & Netea, M. G. Long-term
reprogramming of the innate immune system. J. Leukoc. Biol.
105, 329–338 (2018).
Article  PubMed  CAS  Google Scholar 
16. Berendsen, M. L. T. et al. Maternal priming: bacillus
Calmette-Guérin (BCG) vaccine scarring in mothers enhances
the survival of their child with a BCG vaccine scar. J. Pediatric
Infect. Dis. Soc. https://doi.org/10.1093/jpids/piy142 (2019).
Article  Google Scholar 
17. Moore, R. S., Kaletsky, R. & Murphy, C. T. Piwi/PRG-1
argonaute and TGF-β mediate transgenerational learned
pathogenic avoidance. Cell 177, 1827–1841 (2019).
Article  CAS  PubMed  PubMed Central  Google Scholar 


18. Hirano, M., Das, S., Guo, P. & Cooper, M. D. The evolution of
adaptive immunity in vertebrates. in. Adv. Immunol. 109,
125–157 (2011).
Article  CAS  PubMed  Google Scholar 
19. Cooper, M. D. & Alder, M. N. The evolution of adaptive
immune systems. Cell 124, 815–822 (2006).
Article  CAS  PubMed  Google Scholar 
20. Purvis, A. & Hector, A. Getting the measure of biodiversity.
Nature 405, 212–219 (2000).
Article  CAS  PubMed  Google Scholar 
21. Milutinović, B. & Kurtz, J. Immune memory in invertebrates.
Semin. Immunol. 28, 328–342 (2016).
Article  PubMed  CAS  Google Scholar 
22. Reimer-Michalski, E.-M. & Conrath, U. Innate immune
memory in plants. Semin. Immunol. 28, 319–327 (2016).
Article  CAS  PubMed  Google Scholar 
23. Kleinnijenhuis, J. et al. Bacille Calmette-Guerin induces
NOD2-dependent nonspecific protection from reinfection via
epigenetic reprogramming of monocytes. Proc. Natl Acad. Sci.
USA 109, 17537–17542 (2012).
Article  CAS  PubMed  PubMed Central  Google Scholar 
24. Di Luzio, N. R. & Williams, D. L. Protective effect of glucan
against systemic Staphylococcus aureus septicemia in normal
and leukemic mice. Infect. Immun. 20, 804–810 (1978).
Article  PubMed  PubMed Central  Google Scholar 
25. Marakalala, M. J. et al. Dectin-1 plays a redundant role in the
immunomodulatory activities of β-glucan-rich ligands in vivo.
Microbes Infect. 15, 511–515 (2013).


Article  CAS  PubMed  PubMed Central  Google Scholar 
26. Krahenbuhl, J. L., Sharma, S. D., Ferraresi, R. W. &
Remington, J. S. Effects of muramyl dipeptide treatment on
resistance to infection with Toxoplasma gondii in mice. Infect.
Immun. 31, 716–722 (1981).
Article  CAS  PubMed  PubMed Central  Google Scholar 
27. Ribes, S. et al. Intraperitoneal prophylaxis with CpG
oligodeoxynucleotides protects neutropenic mice against
intracerebral Escherichia coli K1 infection. J.
Neuroinflammation 11, 14 (2014).
Article  PubMed  PubMed Central  CAS  Google Scholar 
28. Muñoz, N. et al. Mucosal administration of flagellin protects
mice from Streptococcus pneumoniae lung infection. Infect.
Immun. 78, 4226–4233 (2010).
Article  PubMed  PubMed Central  CAS  Google Scholar 
29. Zhang, B. et al. Viral infection. Prevention and cure of
rotavirus infection via TLR5/NLRC4-mediated production of
IL-22 and IL-18. Science 346, 861–865 (2014).
Article  CAS  PubMed  PubMed Central  Google Scholar 
30. van’t Wout, J. W., Poell, R. & van Furth, R. The role of BCG/
PPD-activated macrophages in resistance against systemic
candidiasis in mice. Scand. J. Immunol. 36, 713–719 (1992).
Article  Google Scholar 
31. Tribouley, J., Tribouley-Duret, J. & Appriou, M. Effect of
bacillus Callmette Guerin (BCG) on the receptivity of nude
mice to Schistosoma mansoni. C. R. Seances Soc. Biol. Fil. 172,
902–904 (1978).
CAS  PubMed  Google Scholar 
32. Kaufmann, E. et al. BCG educates hematopoietic stem cells to


generate protective innate immunity against tuberculosis. Cell
172, 176–190.e19 (2018). This article shows that access of
BCG to the bone marrow changes the transcriptional
landscape of HSCs and multipotent progenitors, leading
to local cell expansion and enhanced myelopoiesis.
Article  CAS  PubMed  Google Scholar 
33. Bromuro, C. et al. Interplay between protective and inhibitory
antibodies dictates the outcome of experimentally
disseminated candidiasis in recipients of a Candida albicans
vaccine. Infect. Immun. 70, 5462–5470 (2002).
Article  CAS  PubMed  PubMed Central  Google Scholar 
34. Polonelli, L. et al. Therapeutic activity of an engineered
synthetic killer antiidiotypic antibody fragment against
experimental mucosal and systemic candidiasis. Infect. Immun.
71, 6205–6212 (2003).
Article  CAS  PubMed  PubMed Central  Google Scholar 
35. Bistoni, F. et al. Evidence for macrophage-mediated
protection against lethal Candida albicans infection. Infect.
Immun. 51, 668–674 (1986).
Article  CAS  PubMed  PubMed Central  Google Scholar 
36. Bistoni, F. et al. Immunomodulation by a low-virulence,
agerminative variant of Candida albicans. Further evidence for
macrophage activation as one of the effector mechanisms of
nonspecific anti-infectious protection. J. Med. Vet. Mycol. 26,
285–299 (1988).
Article  CAS  PubMed  Google Scholar 
37. Quintin, J. et al. Candida albicans infection affords protection
against reinfection via functional reprogramming of
monocytes. Cell Host Microbe 12, 223–232 (2012).
Article  CAS  PubMed  Google Scholar 


38. Vecchiarelli, A. et al. Protective immunity induced by low-
virulence Candida albicans: cytokine production in the
development of the anti-infectious state. Cell. Immunol. 124,
334–344 (1989).
Article  CAS  PubMed  Google Scholar 
39. Tso, G. H. W. et al. Experimental evolution of a fungal
pathogen into a gut symbiont. Science 362, 589–595 (2018).
Article  CAS  PubMed  Google Scholar 
40. Biering-Sørensen, S. et al. Early BCG-Denmark and neonatal
mortality among infants weighing <2500 g: a randomized
controlled trial. Clin. Infect. Dis. 65, 1183–1190 (2017).
Article  PubMed  PubMed Central  Google Scholar 
41. Rieckmann, A. et al. Vaccinations against smallpox and
tuberculosis are associated with better long-term survival: a
Danish case-cohort study 1971–2010. Int. J. Epidemiol. 46,
695–705 (2017). This study finds that vaccinia and BCG
vaccinations are associated with greater long-term
survival, which is not explained by the pathogen-specific
immune protection that these vaccines offer.
PubMed  Google Scholar 
42. Aaby, P. et al. Vaccinia scars associated with better survival
for adults. An observational study from Guinea-Bissau.
Vaccine 24, 5718–5725 (2006).
Article  PubMed  Google Scholar 
43. Aaby, P. et al. Randomized trial of BCG vaccination at birth
to low-birth-weight children: beneficial nonspecific effects in
the neonatal period? J. Infect. Dis. 204, 245–252 (2011).
Article  CAS  PubMed  Google Scholar 
44. Aaby, P. et al. Non-specific beneficial effect of measles
immunisation: analysis of mortality studies from developing


countries. BMJ 311, 481–485 (1995). This study reports
that the standard-titre measles vaccine may confer a
beneficial effect that is unrelated to specific protection
against measles infection.
Article  CAS  PubMed  PubMed Central  Google Scholar 
45. Aaby, P. et al. Non-specific effects of standard measles
vaccine at 4.5 and 9 months of age on childhood mortality:
randomised controlled trial. BMJ 341, c6495 (2010).
Article  PubMed  PubMed Central  Google Scholar 
46. Lund, N. et al. The effect of oral polio vaccine at birth on
infant mortality: a randomized trial. Clin. Infect. Dis. 61,
1504–1511 (2015).
Article  PubMed  PubMed Central  Google Scholar 
47. Andersen, A. et al. National immunization campaigns with
oral polio vaccine reduce all-cause mortality: a natural
experiment within seven randomized trials. Front. Public
Health 6, 13 (2018).
Article  PubMed  PubMed Central  Google Scholar 
48. Benn, C. S., Netea, M. G., Selin, L. K. & Aaby, P. A small jab -
a big effect: nonspecific immunomodulation by vaccines.
Trends Immunol. 34, 431–439 (2013).
Article  CAS  PubMed  Google Scholar 
49. Kleinnijenhuis, J. et al. BCG-induced trained immunity in NK
cells: role for non-specific protection to infection. Clin.
Immunol. 155, 213–219 (2014).
Article  CAS  PubMed  PubMed Central  Google Scholar 
50. Jensen, K. J. et al. Heterologous immunological effects of
early BCG vaccination in low-birth-weight infants in Guinea-
Bissau: a randomized-controlled trial. J. Infect. Dis. 211, 956–
967 (2015).


Article  CAS  PubMed  Google Scholar 
51. Freyne, B. et al. Neonatal BCG vaccination influences
cytokine responses to toll-like receptor ligands and
heterologous antigens. J. Infect. Dis. 217, 1798–1808 (2018).
Article  CAS  PubMed  Google Scholar 
52. Aaby, P. et al. Differences in female-male mortality after
high-titre measles vaccine and association with subsequent
vaccination with diphtheria-tetanus-pertussis and inactivated
poliovirus: reanalysis of West African studies. Lancet 361,
2183–2188 (2003).
Article  PubMed  Google Scholar 
53. Blok, B. A. et al. Interacting non-specific immunological
effects of BCG and TDAPF vaccinations: an explorative
randomized trial. Clin. Infect. Dis. 70, 455–463 (2019).
Google Scholar 
54. Arts, R. J. W. et al. BCG vaccination protects against
experimental viral infection in humans through the induction
of cytokines associated with trained immunity. Cell Host
Microbe 23, 89–100 (2018).
Article  CAS  PubMed  Google Scholar 
55. Walk, J. et al. Outcomes of controlled human malaria
infection after BCG vaccination. Nat. Commun. 10, 874
(2019).
Article  PubMed  PubMed Central  Google Scholar 
56. McCall, M. B. B. et al. Plasmodium falciparum infection causes
proinflammatory priming of human TLR responses. J.
Immunol. 179, 162–171 (2007).
Article  CAS  PubMed  Google Scholar 
57. Ataide, M. A. et al. Malaria-induced NLRP12/NLRP3-


dependent caspase-1 activation mediates inflammation and
hypersensitivity to bacterial superinfection. PLoS Pathog. 10,
e1003885 (2014).
Article  PubMed  PubMed Central  CAS  Google Scholar 
58. Fitzgerald, K. A. et al. Cutting edge: Plasmodium falciparum
induces trained innate immunity. J. Immunol. 6, 1243–1248
(2018).
Google Scholar 
59. Redelman-Sidi, G., Glickman, M. S. & Bochner, B. H. The
mechanism of action of BCG therapy for bladder cancer—a
current perspective. Nat. Rev. Urol. 11, 153–162 (2014).
Article  CAS  PubMed  Google Scholar 
60. Stewart, J. H. & Levine, E. A. Role of bacillus Calmette-Guérin
in the treatment of advanced melanoma. Expert. Rev.
Anticancer. Ther. 11, 1671–1676 (2011).
Article  PubMed  Google Scholar 
61. Powles, R. L. et al. Maintenance of remission in acute
myelogenous leukaemia by a mixture of B.C.G. and irradiated
leukaemia cells. Lancet 2, 1107–1110 (1977).
Article  CAS  PubMed  Google Scholar 
62. Villumsen, M. et al. Risk of lymphoma and leukaemia after
bacille Calmette-Guérin and smallpox vaccination: a Danish
case-cohort study. Vaccine 27, 6950–6958 (2009).
Article  PubMed  Google Scholar 
63. Buffen, K. et al. Autophagy controls BCG-induced trained
immunity and the response to intravesical BCG therapy for
bladder cancer. PLoS Pathog. 10, e1004485 (2014).
Article  PubMed  PubMed Central  CAS  Google Scholar 


64. Foster, S. L., Hargreaves, D. C. & Medzhitov, R. Gene-specific
control of inflammation by TLR-induced chromatin
modifications. Nature 447, 972–978 (2007).
Article  CAS  PubMed  Google Scholar 
65. Saeed, S. et al. Epigenetic programming of monocyte-to-
macrophage differentiation and trained innate immunity.
Science 345, 1251086 (2014). This article shows that
modification of the epigenetic landscape is behind the
effects of trained immunity in human monocytes.
Article  PubMed  PubMed Central  CAS  Google Scholar 
66. Chen, F. et al. Neutrophils prime a long-lived effector
macrophage phenotype that mediates accelerated helminth
expulsion. Nat. Immunol. 15, 938–946 (2014).
Article  CAS  PubMed  PubMed Central  Google Scholar 
67. Hole, C. R. et al. Induction of memory-like dendritic cell
responses in vivo. Nat. Commun. 10, 2955 (2019).
Article  PubMed  PubMed Central  CAS  Google Scholar 
68. Barton, E. S. et al. Herpesvirus latency confers symbiotic
protection from bacterial infection. Nature 447, 326–329
(2007).
Article  CAS  PubMed  Google Scholar 
69. Sun, J. C., Beilke, J. N. & Lanier, L. L. Adaptive immune
features of natural killer cells. Nature 457, 557–561 (2009).
Article  CAS  PubMed  PubMed Central  Google Scholar 
70. Sun, J. C. et al. Proinflammatory cytokine signaling required
for the generation of natural killer cell memory. J. Exp. Med.
209, 947–954 (2012).
Article  CAS  PubMed  PubMed Central  Google Scholar 


71. Björkström, N. K. et al. Rapid expansion and long-term
persistence of elevated NK cell numbers in humans infected
with hantavirus. J. Exp. Med. 208, 13–21 (2011).
Article  PubMed  PubMed Central  CAS  Google Scholar 
72. Della Chiesa, M. et al. Phenotypic and functional
heterogeneity of human NK cells developing after umbilical
cord blood transplantation: a role for human
cytomegalovirus? Blood 119, 399–410 (2012).
Article  PubMed  CAS  Google Scholar 
73. Foley, B. et al. Human cytomegalovirus (CMV)-induced
memory-like NKG2C+ NK cells are transplantable and expand
in vivo in response to recipient CMV antigen. J. Immunol.
189, 5082–5088 (2012).
Article  CAS  PubMed  Google Scholar 
74. Arase, H., Mocarski, E. S., Campbell, A. E., Hill, A. B. &
Lanier, L. L. Direct recognition of cytomegalovirus by
activating and inhibitory NK cell receptors. Science 296,
1323–1326 (2002).
Article  CAS  PubMed  Google Scholar 
75. Brown, M. G. et al. Vital involvement of a natural killer cell
activation receptor in resistance to viral infection. Science
292, 934–937 (2001).
Article  CAS  PubMed  Google Scholar 
76. Adams, N. M. et al. Cytomegalovirus infection drives avidity
selection of natural killer cells. Immunity 50, 1381–1390.e5
(2019).
Article  CAS  PubMed  PubMed Central  Google Scholar 
77. Grassmann, S. et al. Distinct surface expression of activating
receptor Ly49H drives differential expansion of NK cell clones
upon murine cytomegalovirus infection. Immunity 50, 1391–


1400.e4 (2019).
Article  CAS  PubMed  Google Scholar 
78. Sun, J. C. & Lanier, L. L. NK cell development, homeostasis
and function: parallels with CD8+ T cells. Nat. Rev. Immunol.
11, 645–657 (2011).
Article  CAS  PubMed  PubMed Central  Google Scholar 
79. Min-Oo, G. & Lanier, L. L. Cytomegalovirus generates long-
lived antigen-specific NK cells with diminished bystander
activation to heterologous infection. J. Exp. Med. 211, 2669–
2680 (2014).
Article  CAS  PubMed  PubMed Central  Google Scholar 
80. Rölle, A. et al. IL-12–producing monocytes and HLA-E control
HCMV-driven NKG2C+ NK cell expansion. J. Clin. Invest. 124,
5305–5316 (2014).
Article  PubMed  PubMed Central  Google Scholar 
81. Hammer, Q. et al. Peptide-specific recognition of human
cytomegalovirus strains controls adaptive natural killer cells.
Nat. Immunol. 19, 453–463 (2018).
Article  CAS  PubMed  Google Scholar 
82. Karo, J. M., Schatz, D. G. & Sun, J. C. The RAG recombinase
dictates functional heterogeneity and cellular fitness in
natural killer cells. Cell 159, 94–107 (2014).
Article  CAS  PubMed  PubMed Central  Google Scholar 
83. Vivier, E. et al. Innate or adaptive immunity? The example of
natural killer cells. Science 331, 44–49 (2011).
Article  CAS  PubMed  PubMed Central  Google Scholar 
84. Cooper, M. A. et al. Cytokine-induced memory-like natural
killer cells. Proc. Natl Acad. Sci. USA 106, 1915–1919 (2009).


Article  CAS  PubMed  PubMed Central  Google Scholar 
85. Romee, R. et al. Cytokine activation induces human memory-
like NK cells. Blood 120, 4751–4760 (2012).
Article  CAS  PubMed  PubMed Central  Google Scholar 
86. Romee, R. et al. Cytokine-induced memory-like natural killer
cells exhibit enhanced responses against myeloid leukemia.
Sci. Transl Med. 8, 357ra123 (2016).
Article  PubMed  PubMed Central  CAS  Google Scholar 
87. Madera, S. et al. Type I IFN promotes NK cell expansion
during viral infection by protecting NK cells against fratricide.
J. Exp. Med. 213, 225–233 (2016).
Article  CAS  PubMed  PubMed Central  Google Scholar 
88. Madera, S. & Sun, J. C. Cutting edge: stage-specific
requirement of IL-18 for antiviral NK cell expansion. J.
Immunol. 194, 1408–1412 (2015).
Article  CAS  PubMed  Google Scholar 
89. Nabekura, T., Girard, J.-P. & Lanier, L. L. IL-33 receptor ST2
amplifies the expansion of NK cells and enhances host defense
during mouse cytomegalovirus infection. J. Immunol. 194,
5948–5952 (2015).
Article  CAS  PubMed  Google Scholar 
90. Weizman, O.-E. et al. Mouse cytomegalovirus-experienced
ILC1s acquire a memory response dependent on the viral
glycoprotein m12. Nat. Immunol. 20, 1004–1011 (2019).
Article  CAS  PubMed  PubMed Central  Google Scholar 
91. Martinez-Gonzalez, I. et al. Allergen-experienced group 2
innate lymphoid cells acquire memory-like properties and
enhance allergic lung inflammation. Immunity 45, 198–208
(2016).


Article  CAS  PubMed  Google Scholar 
92. Paust, S. et al. Critical role for the chemokine receptor CXCR6
in NK cell–mediated antigen-specific memory of haptens and
viruses. Nat. Immunol. 11, 1127–1135 (2010).
Article  CAS  PubMed  PubMed Central  Google Scholar 
93. Gamliel, M. et al. Trained memory of human uterine NK cells
enhances their function in subsequent pregnancies. Immunity
48, 951–962 (2018). This study finds that uterine NK cells
adapt to pregnancy and can better support subsequent
pregnancies.
Article  CAS  PubMed  Google Scholar 
94. Gonzales, K. A. U. & Fuchs, E. Skin and its regenerative
powers: an alliance between stem cells and their niche. Dev.
Cell 43, 387–401 (2017).
Article  CAS  PubMed  Google Scholar 
95. Naik, S., Larsen, S. B., Cowley, C. J. & Fuchs, E. Two to tango:
dialog between immunity and stem cells in health and
disease. Cell 175, 908–920 (2018).
Article  CAS  PubMed  PubMed Central  Google Scholar 
96. Biton, M. et al. T helper cell cytokines modulate intestinal
stem cell renewal and differentiation. Cell 175, 1307–1320
(2018).
Article  CAS  PubMed  PubMed Central  Google Scholar 
97. Lindemans, C. A. et al. Interleukin-22 promotes intestinal-
stem-cell-mediated epithelial regeneration. Nature 528, 560–
564 (2015).
Article  CAS  PubMed  PubMed Central  Google Scholar 
98. von Moltke, J., Ji, M., Liang, H.-E. & Locksley, R. M. Tuft-cell-
derived IL-25 regulates an intestinal ILC2–epithelial response


circuit. Nature 529, 221–225 (2016).
Article  CAS  Google Scholar 
99. Kamada, R. et al. Interferon stimulation creates chromatin
marks and establishes transcriptional memory. Proc. Natl
Acad. Sci. USA 115, E9162–E9171 (2018).
Article  CAS  PubMed  PubMed Central  Google Scholar 
100. Merad, M., Sathe, P., Helft, J., Miller, J. & Mortha, A. The
dendritic cell lineage: ontogeny and function of dendritic cells
and their subsets in the steady state and the inflamed setting.
Annu. Rev. Immunol. 31, 563–604 (2013).
Article  CAS  PubMed  Google Scholar 
101. Yona, S. et al. Fate mapping reveals origins and dynamics of
monocytes and tissue macrophages under homeostasis.
Immunity 38, 79–91 (2013).
Article  CAS  PubMed  Google Scholar 
102. Patel, A. A. et al. The fate and lifespan of human monocyte
subsets in steady state and systemic inflammation. J. Exp.
Med. 214, 1913–1923 (2017).
Article  CAS  PubMed  PubMed Central  Google Scholar 
103. Chavakis, T., Mitroulis, I. & Hajishengallis, G. Hematopoietic
progenitor cells as integrative hubs for adaptation to and fine-
tuning of inflammation. Nat. Immunol. 20, 802–811 (2019).
Article  CAS  PubMed  PubMed Central  Google Scholar 
104. Mitroulis, I. et al. Modulation of myelopoiesis progenitors is
an integral component of trained immunity. Cell 172, 147–
161 (2018). This study shows that the induction of trained
immunity modulates metabolism of haematopoietic
progenitors in the bone marrow and increases
myelopoiesis.


Article  CAS  PubMed  PubMed Central  Google Scholar 
105. Ordovas-Montanes, J. et al. Allergic inflammatory memory in
human respiratory epithelial progenitor cells. Nature 560,
649–654 (2018). This article shows that epithelial stem
cells contribute to the persistence of human disease by
serving as repositories for allergic memories.
Article  CAS  PubMed  PubMed Central  Google Scholar 
106. Machiels, B. et al. A gammaherpesvirus provides protection
against allergic asthma by inducing the replacement of
resident alveolar macrophages with regulatory monocytes.
Nat. Immunol. 18, 1310–1320 (2017).
Article  CAS  PubMed  Google Scholar 
107. Yao, Y. et al. Induction of autonomous memory alveolar
macrophages requires T cell help and is critical to trained
immunity. Cell 175, 1634–1650.e17 (2018). This study finds
that the formation and maintenance of alveolar
macrophages showing memory features occurs
independently of monocytes or bone marrow progenitors.
Article  CAS  PubMed  Google Scholar 
108. Smale, S. T., Tarakhovsky, A. & Natoli, G. Chromatin
contributions to the regulation of innate immunity. Annu.
Rev. Immunol. 32, 489–511 (2014).
Article  CAS  PubMed  Google Scholar 
109. Ghisletti, S. et al. Identification and characterization of
enhancers controlling the inflammatory gene expression
program in macrophages. Immunity 32, 317–328 (2010).
Article  CAS  PubMed  Google Scholar 
110. Fanucchi, S. et al. Immune genes are primed for robust
transcription by proximal long noncoding RNAs located in
nuclear compartments. Nat. Genet. 51, 138–150 (2019). This
study hows that lncRNA-mediated regulation is central to


the establishment of trained immunity.
Article  CAS  PubMed  Google Scholar 
111. Natoli, G. & Ostuni, R. Adaptation and memory in immune
responses. Nat. Immunol. 20, 783–792 (2019).
Article  CAS  PubMed  Google Scholar 
112. Luetke-Eversloh, M. et al. Human cytomegalovirus drives
epigenetic imprinting of the IFNG locus in NKG2Chi natural
killer cells. PLoS Pathog. 10, e1004441 (2014).
Article  PubMed  PubMed Central  CAS  Google Scholar 
113. Lau, C. M. et al. Epigenetic control of innate and adaptive
immune memory. Nat. Immunol. 19, 963–972 (2018).
Article  CAS  PubMed  PubMed Central  Google Scholar 
114. Rapp, M. et al. Core-binding factor β and Runx transcription
factors promote adaptive natural killer cell responses. Sci.
Immunol. 2, eaan3796 (2017).
Article  PubMed  PubMed Central  Google Scholar 
115. Geary, C. D. et al. Non-redundant ISGF3 components promote
NK cell survival in an auto-regulatory manner during viral
infection. Cell Rep. 24, 1949–1957.e6 (2018).
Article  CAS  PubMed  PubMed Central  Google Scholar 
116. Lam, V. C., Folkersen, L., Aguilar, O. A. & Lanier, L. L. KLF12
regulates mouse NK cell proliferation. J. Immunol. 203, 981–
989 (2019).
Article  CAS  PubMed  Google Scholar 
117. Adams, N. M. et al. Transcription factor IRF8 orchestrates the
adaptive natural killer cell response. Immunity 48, 1172–
1182.e6 (2018).


Article  CAS  PubMed  PubMed Central  Google Scholar 
118. Madera, S. et al. Cutting edge: divergent requirement of T-box
transcription factors in effector and memory NK cells. J.
Immunol. 200, 1977–1981 (2018).
Article  CAS  PubMed  Google Scholar 
119. Zawislak, C. L. et al. Stage-specific regulation of natural killer
cell homeostasis and response against viral infection by
microRNA-155. Proc. Natl Acad. Sci. USA 110, 6967–6972
(2013).
Article  CAS  PubMed  PubMed Central  Google Scholar 
120. Lu, L.-F. et al. A single miRNA-mRNA interaction affects the
immune response in a context- and cell-type-specific manner.
Immunity 43, 52–64 (2015).
Article  CAS  PubMed  PubMed Central  Google Scholar 
121. O’Connell, R. M., Chaudhuri, A. A., Rao, D. S. & Baltimore, D.
Inositol phosphatase SHIP1 is a primary target of miR-155.
Proc. Natl Acad. Sci. USA 106, 7113–7118 (2009).
Article  PubMed  PubMed Central  Google Scholar 
122. Saz-Leal, P. et al. Targeting SHIP-1 in myeloid cells enhances
trained immunity and boosts response to infection. Cell Rep.
25, 1118–1126 (2018).
Article  CAS  PubMed  PubMed Central  Google Scholar 
123. Verma, D. et al. Anti-mycobacterial activity correlates with
altered DNA methylation pattern in immune cells from BCG-
vaccinated subjects. Sci. Rep. 7, 12305 (2017).
Article  PubMed  PubMed Central  CAS  Google Scholar 
124. Das, J., Verma, D., Gustafsson, M. & Lerm, M. Identification
of DNA methylation patterns predisposing for an efficient
response to BCG vaccination in healthy BCG-naïve subjects.


Epigenetics 14, 589–601 (2019).
Article  PubMed  PubMed Central  Google Scholar 
125. Penkov, S., Mitroulis, I., Hajishengallis, G. & Chavakis, T.
Immunometabolic crosstalk: an ancestral principle of trained
immunity? Trends Immunol. 40, 1–11 (2019).
Article  CAS  PubMed  Google Scholar 
126. Norata, G. D. et al. The cellular and molecular basis of
translational immunometabolism. Immunity 43, 421–434
(2015).
Article  CAS  PubMed  Google Scholar 
127. Domínguez-Andrés, J., Joosten, L. A. & Netea, M. G.
Induction of innate immune memory: the role of cellular
metabolism. Curr. Opin. Immunol. 56, 10–16 (2019).
Article  PubMed  CAS  Google Scholar 
128. Donohoe, D. R. & Bultman, S. J. Metaboloepigenetics:
interrelationships between energy metabolism and epigenetic
control of gene expression. J. Cell. Physiol. 227, 3169–3177
(2012).
Article  CAS  PubMed  PubMed Central  Google Scholar 
129. Cheng, S.-C. et al. mTOR- and HIF-1-mediated aerobic
glycolysis as metabolic basis for trained immunity. Science
345, 1250684–1250684 (2014). This study reports that
metabolic rewiring of cells is crucial for the induction of
trained immunity.
Article  PubMed  PubMed Central  CAS  Google Scholar 
130. Arts, R. J. W. et al. Immunometabolic pathways in BCG-
induced trained immunity. Cell Rep. 17, 2562–2571 (2016).
Article  CAS  PubMed  PubMed Central  Google Scholar 


131. Arts, R. J. W. et al. Glutaminolysis and fumarate
accumulation integrate immunometabolic and epigenetic
programs in trained immunity. Cell Metab. https://
doi.org/10.1016/j.cmet.2016.10.008 (2016).
Article  PubMed  PubMed Central  Google Scholar 
132. Liu, P.-S. et al. α-Ketoglutarate orchestrates macrophage
activation through metabolic and epigenetic reprogramming.
Nat. Immunol. 18, 985–994 (2017).
Article  CAS  PubMed  Google Scholar 
133. Tannahill, G. M. et al. Succinate is an inflammatory signal
that induces IL-1β through HIF-1α. Nature 496, 238–242
(2013).
Article  CAS  PubMed  PubMed Central  Google Scholar 
134. Lampropoulou, V. et al. Itaconate links inhibition of succinate
dehydrogenase with macrophage metabolic remodeling and
regulation of inflammation. Cell Metab. 24, 158–166 (2016).
Article  CAS  PubMed  PubMed Central  Google Scholar 
135. Cordes, T. et al. Immunoresponsive gene 1 and itaconate
inhibit succinate dehydrogenase to modulate intracellular
succinate levels. J. Biol. Chem. 291, 14274–14284 (2016).
Article  CAS  PubMed  PubMed Central  Google Scholar 
136. Mills, E. L. et al. Itaconate is an anti-inflammatory metabolite
that activates Nrf2 via alkylation of KEAP1. Nature 556, 113–
117 (2018).
Article  CAS  PubMed  PubMed Central  Google Scholar 
137. Bambouskova, M. et al. Electrophilic properties of itaconate
and derivatives regulate the IκBζ–ATF3 inflammatory axis.
Nature 556, 501–504 (2018).
Article  CAS  PubMed  PubMed Central  Google Scholar 


138. Dominguez-Andres, J. et al. The itaconate pathway is a
central regulatory node linking innate immune tolerance and
trained immunity. Cell Metab. 29, 211–220 (2018).
Article  PubMed  CAS  Google Scholar 
139. Bekkering, S. et al. Metabolic induction of trained immunity
through the mevalonate pathway. Cell 172, 135–146.e9
(2018).
Article  CAS  PubMed  Google Scholar 
140. Yvan-Charvet, L. et al. ATP-binding cassette transporters and
HDL suppress hematopoietic stem cell proliferation. Science
328, 1689–1693 (2010).
Article  CAS  PubMed  PubMed Central  Google Scholar 
141. Murphy, A. J. et al. ApoE regulates hematopoietic stem cell
proliferation, monocytosis, and monocyte accumulation in
atherosclerotic lesions in mice. J. Clin. Invest. 121, 4138–4149
(2011).
Article  CAS  PubMed  PubMed Central  Google Scholar 
142. Christ, A. & Latz, E. The Western lifestyle has lasting effects
on metaflammation. Nat. Rev. Immunol. 19, 267–268 (2019).
Article  CAS  PubMed  Google Scholar 
143. Musher, D. M., Abers, M. S. & Corrales-Medina, V. F. Acute
infection and myocardial infarction. N. Engl. J. Med. 380,
171–176 (2019).
Article  CAS  PubMed  Google Scholar 
144. Leentjens, J. et al. Trained innate immunity as a novel
mechanism linking infection and the development of
atherosclerosis. Circ. Res. 122, 664–669 (2018).
Article  CAS  PubMed  Google Scholar 


145. Bekkering, S. et al. Oxidized low-density lipoprotein induces
long-term proinflammatory cytokine production and foam cell
formation via epigenetic reprogramming of monocytes.
Arterioscler. Thromb. Vasc. Biol. 34, 1731–1738 (2014).
Article  CAS  PubMed  Google Scholar 
146. Braza, M. S. et al. Inhibiting inflammation with myeloid cell-
specific nanobiologics promotes organ transplant acceptance.
Immunity 49, 819–828 (2018).
Article  CAS  PubMed  PubMed Central  Google Scholar 
147. van der Valk, F. M. et al. Oxidized phospholipids on
lipoprotein(a) elicit arterial wall inflammation and an
inflammatory monocyte response in humans. Circulation 134,
611–624 (2016).
Article  PubMed  PubMed Central  CAS  Google Scholar 
148. Bekkering, S. et al. Treatment with statins does not revert
trained immunity in patients with familial
hypercholesterolemia. Cell Metab. 30, 1–2 (2019).
Article  CAS  PubMed  Google Scholar 
149. Bekkering, S. et al. Innate immune cell activation and
epigenetic remodeling in symptomatic and asymptomatic
atherosclerosis in humans in vivo. Atherosclerosis 254, 228–
236 (2016).
Article  CAS  PubMed  Google Scholar 
150. Shirai, T. et al. The glycolytic enzyme PKM2 bridges
metabolic and inflammatory dysfunction in coronary artery
disease. J. Exp. Med. 213, 337–354 (2016).
Article  CAS  PubMed  PubMed Central  Google Scholar 
151. Zimmermann, P., Finn, A. & Curtis, N. Does BCG vaccination
protect against nontuberculous mycobacterial infection? A
systematic review and meta-analysis. J. Infect. Dis. 218, 679–


687 (2018).
Article  CAS  PubMed  Google Scholar 
152. Leentjens, J. et al. BCG vaccination enhances the
immunogenicity of subsequent influenza vaccination in
healthy volunteers: a randomized, placebo-controlled pilot
study. J. Infect. Dis. 212, 1930–1938 (2015).
Article  CAS  PubMed  Google Scholar 
153. Ransohoff, R. M. How neuroinflammation contributes to
neurodegeneration. Science 353, 777–783 (2016).
Article  CAS  PubMed  Google Scholar 
154. Wendeln, A.-C. et al. Innate immune memory in the brain
shapes neurological disease hallmarks. Nature 556, 332–338
(2018).
Article  CAS  PubMed  PubMed Central  Google Scholar 
155. Frost, P. S. et al. Neonatal infection leads to increased
susceptibility to Aβ oligomer-induced brain inflammation,
synapse loss and cognitive impairment in mice. Cell Death Dis.
10, 323 (2019).
Article  PubMed  PubMed Central  CAS  Google Scholar 
156. Low, A., Mak, E., Rowe, J. B., Markus, H. S. & O’Brien, J. T.
Inflammation and cerebral small vessel disease: a systematic
review. Ageing Res. Rev. 53, 100916 (2019).
Article  CAS  PubMed  Google Scholar 
157. Noz, M. P. et al. Trained immunity characteristics are
associated with progressive cerebral small vessel disease.
Stroke 49, 2910–2917 (2018).
Article  PubMed  Google Scholar 
158. Franceschi, C. et al. Immunobiography and the heterogeneity


of immune responses in the elderly: a focus on inflammaging
and trained immunity. Front. Immunol. 8, 982 (2017).
Article  PubMed  PubMed Central  CAS  Google Scholar 
159. Qian, F. et al. Age-associated elevation in TLR5 leads to
increased inflammatory responses in the elderly. Aging Cell
11, 104–110 (2012).
Article  CAS  PubMed  Google Scholar 
160. Metcalf, T. U. et al. Global analyses revealed age-related
alterations in innate immune responses after stimulation of
pathogen recognition receptors. Aging Cell 14, 421–432
(2015).
Article  CAS  PubMed  PubMed Central  Google Scholar 
161. Hoogeboom, R. et al. A mutated B cell chronic lymphocytic
leukemia subset that recognizes and responds to fungi. J. Exp.
Med. 210, 59–70 (2013).
Article  CAS  PubMed  PubMed Central  Google Scholar 
162. Jurado-Camino, T. et al. Chronic lymphocytic leukemia: a
paradigm of innate immune cross-tolerance. J. Immunol. 194,
719–727 (2015).
Article  CAS  PubMed  Google Scholar 
163. Pauken, K. E. et al. Epigenetic stability of exhausted T cells
limits durability of reinvigoration by PD-1 blockade. Science
354, 1160–1165 (2016).
Article  CAS  PubMed  PubMed Central  Google Scholar 
164. Lee, S. H. et al. TNFα enhances cancer stem cell-like
phenotype via Notch-Hes1 activation in oral squamous cell
carcinoma cells. Biochem. Biophys. Res. Commun. 424, 58–64
(2012).
Article  CAS  PubMed  PubMed Central  Google Scholar 


165. Hodge, D. R., Hurt, E. M. & Farrar, W. L. The role of IL-6 and
STAT3 in inflammation and cancer. Eur. J. Cancer 41, 2502–
2512 (2005).
Article  CAS  PubMed  Google Scholar 
166. Rabold, K., Netea, M. G., Adema, G. J. & Netea-Maier, R. T.
Cellular metabolism of tumor-associated macrophages -
functional impact and consequences. FEBS Lett. 591, 3022–
3041 (2017).
Article  CAS  PubMed  Google Scholar 
167. Cubas, P., Vincent, C. & Coen, E. An epigenetic mutation
responsible for natural variation in floral symmetry. Nature
401, 157–161 (1999).
Article  CAS  PubMed  Google Scholar 
168. Greer, E. L. et al. A histone methylation network regulates
transgenerational epigenetic memory in C. elegans. Cell Rep.
7, 113–126 (2014).
Article  CAS  PubMed  PubMed Central  Google Scholar 
169. Tate, A. T., Andolfatto, P., Demuth, J. P. & Graham, A. L. The
within-host dynamics of infection in trans-generationally
primed flour beetles. Mol. Ecol. 26, 3794–3807 (2017).
Article  CAS  PubMed  PubMed Central  Google Scholar 
170. No Authors Listed. Meeting of the Strategic Advisory Group of
Experts on immunization, April 2014 - conclusions and
recommendations. Wkly Epidemiol. Rec. 89, 221–236 (2014).
Google Scholar 
171. Shann, F. The heterologous (non-specific) effects of vaccines:
implications for policy in high-mortality countries. Trans. R.
Soc. Trop. Med. Hyg. 109, 5–8 (2015).
Article  CAS  PubMed  Google Scholar 


172. Benn, C. S., Fisker, A. B., Whittle, H. C. & Aaby, P.
Revaccination with live attenuated vaccines confer additional
beneficial nonspecific effects on overall survival: a review.
EBioMedicine 10, 312–317 (2016).
Article  PubMed  PubMed Central  Google Scholar 
173. Locht, C. & Mielcarek, N. Live attenuated vaccines against
pertussis. Expert. Rev. Vaccines 13, 1147–1158 (2014).
Article  CAS  PubMed  Google Scholar 
174. Meyers, P. A. et al. Osteosarcoma: the addition of muramyl
tripeptide to chemotherapy improves overall survival-a report
from the Children’s Oncology Group. J. Clin. Oncol. 26, 633–
638 (2008).
Article  CAS  PubMed  Google Scholar 
175. Muramatsu, D. et al. β-glucan derived from Aureobasidium
pullulans is effective for the prevention of influenza in mice.
PLoS One 7, e41399 (2012).
Article  CAS  PubMed  PubMed Central  Google Scholar 
176. Mulder, W. J. M., Ochando, J., Joosten, L. A. B., Fayad, Z. A.
& Netea, M. G. Therapeutic targeting of trained immunity.
Nat. Rev. Drug. Discov. 18, 553–566 (2019).
Article  CAS  PubMed  PubMed Central  Google Scholar 
177. Levine, D. B. The Hospital for the Ruptured and Crippled:
William Bradley Coley, third Surgeon-in-Chief 1925-1933.
HSS J. 4, 1–9 (2008).
Article  PubMed  Google Scholar 
178. Coley, W. B. II. Contribution to the knowledge of sarcoma.
Ann. Surg. 14, 199–220 (1891).
Article  CAS  PubMed  PubMed Central  Google Scholar 


179. Old, L. J., Clarke, D. A. & Benacerraf, B. Effect of bacillus
Calmette-Guérin infection on transplanted tumours in the
mouse. Nature 184, 291–292 (1959).
Article  PubMed  Google Scholar 
180. Ostadrahimi, A. et al. Effect of beta glucan on white blood
cell counts and serum levels of IL-4 and IL-12 in women with
breast cancer undergoing chemotherapy: a randomized
double-blind placebo-controlled clinical trial. Asian Pac. J.
Cancer Prev. 15, 5733–5739 (2014).
Article  PubMed  Google Scholar 
181. Bashir, K. M. I. & Choi, J.-S. Clinical and physiological
perspectives of β-glucans: the past, present, and future. Int. J.
Mol. Sci. 18, 1906 (2017).
Article  PubMed Central  CAS  Google Scholar 
182. Vetvicka, V., Vannucci, L., Sima, P. & Richter, J. Beta glucan:
supplement or drug? from laboratory to clinical trials.
Molecules 24, 1251 (2019).
Article  PubMed Central  CAS  Google Scholar 
183. Lim, W. A. & June, C. H. The principles of engineering
immune cells to treat. Cancer Cell 168, 724–740 (2017).
CAS  Google Scholar 
184. Sharma, P. & Allison, J. P. The future of immune checkpoint
therapy. Science 348, 56–61 (2015).
Article  CAS  PubMed  Google Scholar 
185. Routy, B. et al. The gut microbiota influences anticancer
immunosurveillance and general health. Nat. Rev. Clin. Oncol.
15, 382–396 (2018).
Article  CAS  PubMed  Google Scholar 


186. Lameijer, M. et al. Efficacy and safety assessment of a TRAF6-
targeted nanoimmunotherapy in atherosclerotic mice and
non-human primates. Nat. Biomed. Eng. 2, 279–292 (2018).
Article  CAS  PubMed  PubMed Central  Google Scholar 
187. Netea, M. G., Schlitzer, A., Placek, K., Joosten, L. A. B. &
Schultze, J. L. Innate and adaptive immune memory: an
evolutionary continuum in the host’s response to pathogens.
Cell Host Microbe 25, 13–26 (2019).
Article  CAS  PubMed  Google Scholar 
188. Ridker, P. M. et al. Antiinflammatory therapy with
canakinumab for atherosclerotic disease. N. Engl. J. Med. 377,
1119–1131 (2017).
Article  CAS  PubMed  Google Scholar 
189. Domínguez-Andrés, J. et al. Bromodomain inhibitor I-BET151
suppresses immune responses during fungal-immune
interaction. Eur. J. Immunol. 49, 2044–2050 (2019).
Article  PubMed  PubMed Central  CAS  Google Scholar 
190. Alqahtani, A. et al. Bromodomain and extra-terminal motif
inhibitors: a review of preclinical and clinical advances in
cancer therapy. Future Sci. OA 5, FSO372 (2019).
Article  PubMed  PubMed Central  CAS  Google Scholar 
Download references
Acknowledgements
M.G.N. was supported by a Spinoza grant from the Netherlands
Organization for Scientific Research and a European Research
Council (ERC) Advanced Grant (no. 833247). E.F. is an Investigator
of the Howard Hughes Medical Institute and is supported by grants
from the US National Institutes of Health (R01-AR31737 and R01-


AR050452) and New York State (C32585GG). J.C.S. is supported by
the Ludwig Center for Cancer Immunotherapy, the American Cancer
Society, the Burroughs Wellcome Fund and the US National
Institutes of Health (AI100874, AI130043 and P30CA008748). E.L.
is supported by grants from the Deutsche Forschungsgemeinschaft
(SFBs 645, 670 and 1123; TRRs 83 and 57), a grant from the US
National Institutes of Health (1R01HL112661) and an ERC
Consolidator grant (InflammAct). J.L.S is supported by grants from
the Deutsche Forschungsgemeinschaft (West German Genome
Center grant, Central Coordination Unit of the national Next-
Generation Sequencing Competence Network) and grants from the
Helmholtz Gemeinschaft (Sparse2Big and AmPro) and the European
Union (SYSCID, no. 733100). E.L., M.G.N., J.L.S. and A.S. are
members of the Immuno-Sensation excellence cluster funded by the
Deutsche Forschungsgemeinschaft under Germany’s Excellence
Strategy (EXC2151 — 390873048). T.C. is supported by an ERC
Consolidator grant (DEMETINL) and by grants from the Deutsche
Forschungsgemeinschaft (SFB 1181, TRR-SFB 205 and TRR-SFB
127). N.P.R., L.A.B.J. and M.G.N. received funding from the
European Union Horizon 2020 research and innovation programme
under grant agreement no. 667837 and the IN-CONTROL grant
from the Dutch Foundation Netherlands (CVON2012-03 and
CVON2018-27). N.P.R. is a recipient of a grant from European
Research Area Network on Cardiovascular Diseases Joint
Transnational Call 2018, which is supported by the Dutch Heart
Foundation (JTC2018, project MEMORY; 2018T093).
Author information
Authors and Affiliations
1. Department of Internal Medicine and Radboud Center for
Infectious Diseases, Radboud University Medical Center,
Nijmegen, Netherlands
Mihai G. Netea, Jorge Domínguez-Andrés, Leo A. B.
Joosten, Jos W. M. van der Meer & Niels P. Riksen
2. Radboud Institute for Molecular Life Sciences, Radboud


University Medical Center, Nijmegen, Netherlands
Mihai G. Netea, Jorge Domínguez-Andrés, Leo A. B.
Joosten, Jos W. M. van der Meer & Niels P. Riksen
3. Department of Genomics and Immunoregulation, Life and
Medical Sciences Institute, University of Bonn, Bonn,
Germany
Mihai G. Netea & Joachim L. Schultze
4. Department of Genetics, CHU Sainte-Justine Research Centre,
Montreal, QC, Canada
Luis B. Barreiro
5. Department of Pediatrics, University of Montreal, Montreal,
QC, Canada
Luis B. Barreiro
6. Genetics Section, Department of Medicine, The University of
Chicago, Chicago, IL, USA
Luis B. Barreiro
7. Institute for Clinical Chemistry and Laboratory Medicine,
University Hospital and Faculty of Medicine Carl Gustav
Carus of TU Dresden, Dresden, Germany
Triantafyllos Chavakis
8. Centre for Cardiovascular Science, Queen’s Medical Research
Institute, University of Edinburgh, Edinburgh, UK
Triantafyllos Chavakis
9. Meakins-Christie Laboratories, Department of Medicine,
McGill University Health Centre, Montreal, QC, Canada
Maziar Divangahi
10. Department of Microbiology and Immunology, McGill


University, Montreal, QC, Canada
Maziar Divangahi
11. McGill International TB Centre, McGill University Health
Centre, Montreal, QC, Canada
Maziar Divangahi
12. Howard Hughes Medical Institute, Robin Chemers Laboratory
of Mammalian Cell Biology and Development, The
Rockefeller University, New York, NY, USA
Elaine Fuchs
13. Division of Chemical and Systems Biology, Department of
Integrative Biomedical Sciences, Faculty of Health Sciences,
Institute of Infectious Disease and Molecular Medicine,
University of Cape Town, Cape Town, South Africa
Musa M. Mhlanga
14. Gene Expression and Biophysics Unit, Instituto de Medicina
Molecular, Faculdade de Medicina Universidade de Lisboa,
Lisbon, Portugal
Musa M. Mhlanga
15. Translational and Molecular Imaging Institute, Department of
Radiology, Icahn School of Medicine at Mount Sinai, New
York, NY, USA
Willem J. M. Mulder
16. Department of Oncological Sciences, Icahn School of
Medicine at Mount Sinai, New York, NY, USA
Willem J. M. Mulder
17. Laboratory of Chemical Biology, Department of Biomedical
Engineering and Institute for Complex Molecular Systems,
Eindhoven University of Technology, Eindhoven, Netherlands


Willem J. M. Mulder
18. Myeloid Cell Biology, Life and Medical Sciences Institute,
University of Bonn, Bonn, Germany
Andreas Schlitzer
19. Bandim Health Project, OPEN, Department of Clinical
Research, University of Southern Denmark, Odense, Denmark
Christine Stabell Benn
20. Immunology Program, Memorial Sloan Kettering Cancer
Center, New York, NY, USA
Joseph C. Sun
21. Louis V. Gerstner Jr. Graduate School of Biomedical Sciences,
Memorial Sloan Kettering Cancer Center, New York, NY, USA
Joseph C. Sun
22. Department of Immunology and Microbial Pathogenesis,
Weill Cornell Medical College, New York, NY, USA
Joseph C. Sun
23. Broad Institute of MIT and Harvard, Cambridge, MA, USA
Ramnik J. Xavier
24. Center for Computational and Integrative Biology,
Massachusetts General Hospital and Harvard Medical School,
Boston, MA, USA
Ramnik J. Xavier
25. Institute of Innate Immunity, University Hospital, University
of Bonn, Bonn, Germany
Eicke Latz
26. Division of Infectious Diseases and Immunology, University of


Massachusetts Medical School, Worcester, MA, USA
Eicke Latz
27. German Center for Neurodegenerative Diseases, Bonn,
Germany
Eicke Latz
Authors
1. Mihai G. Netea
View author publications
Search author on:PubMed Google Scholar
2. Jorge Domínguez-Andrés
View author publications
Search author on:PubMed Google Scholar
3. Luis B. Barreiro
View author publications
Search author on:PubMed Google Scholar
4. Triantafyllos Chavakis
View author publications
Search author on:PubMed Google Scholar
5. Maziar Divangahi
View author publications
Search author on:PubMed Google Scholar
6. Elaine Fuchs
View author publications
Search author on:PubMed Google Scholar
7. Leo A. B. Joosten
View author publications


Search author on:PubMed Google Scholar
8. Jos W. M. van der Meer
View author publications
Search author on:PubMed Google Scholar
9. Musa M. Mhlanga
View author publications
Search author on:PubMed Google Scholar
10. Willem J. M. Mulder
View author publications
Search author on:PubMed Google Scholar
11. Niels P. Riksen
View author publications
Search author on:PubMed Google Scholar
12. Andreas Schlitzer
View author publications
Search author on:PubMed Google Scholar
13. Joachim L. Schultze
View author publications
Search author on:PubMed Google Scholar
14. Christine Stabell Benn
View author publications
Search author on:PubMed Google Scholar
15. Joseph C. Sun
View author publications
Search author on:PubMed Google Scholar
16. Ramnik J. Xavier


View author publications
Search author on:PubMed Google Scholar
17. Eicke Latz
View author publications
Search author on:PubMed Google Scholar
Contributions
The authors contributed equally to all aspects of the article.
Corresponding authors
Correspondence to Mihai G. Netea or Eicke Latz.
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Peer review information
Nature Reviews Immunology thanks H. Goodridge and the other,
anonymous, reviewer(s) for their contribution to the peer review of
this work.
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims
in published maps and institutional affiliations.


Glossary
Pattern recognition receptors
(PRRs). Germline-encoded receptors that recognize
pathogen-associated molecular patterns — evolutionarily
conserved structures associated with pathogens such as
viruses, bacteria, fungi and parasites — and damage-
associated molecular patterns, which are exposed in
damaged host tissues. There are four main families of PRRs:
namely, Toll-like receptors, NOD-like receptors, C-type
lectin receptors and RIG1-like receptors. Interaction of
pathogen-associated molecular patterns with pattern
recognition receptors mediates recognition of pathogens
and triggers inflammation.
Bacillus Calmette–Guérin
(BCG). An attenuated form of the bacterium Mycobacterium
bovis, which is the causative agent of bovine tuberculosis.
Developed at Institut Pasteur at the beginning of the
twentieth century as a vaccine to prevent tuberculosis (BCG
vaccine), it also induces protective heterologous effects
against infections and malignancies.
Myeloid cells
Cells of the immune system that arise from pluripotent
primordial cells in the bone marrow. Myeloid cells
(monocytes, macrophages, dendritic cells and granulocytes)
have many physiological roles, among which are roles are
to destroy the invading pathogens and repair tissues.
Chromatin
A complex structure composed of DNA and proteins located
in the nucleus in which the genetic material of eukaryotic
cells is organized. Chromatin has a high degree of
organization, which allows the compaction of the genetic
material, but this remains reachable to allow access of the
protein machinery that regulates gene transcription.


Chemical modification of histones, the core proteins in
chromatin, regulates the accessibility of the DNA for the
transcription machinery.
Topologically associated domains
(TADs). Large domains of about 0.5 to 2 million base pairs
into which chromosomes rolled up in loops are organized,
where different regions frequently interact with each other,
allowing gene promoters to interact with all their regions’
regulators even over long distances. Within each TAD,
several genes and the elements that regulate them are
packaged together and are isolated from neighbouring
TADs.
Rights and permissions
Reprints and permissions
About this article
[image]
Cite this article
Netea, M.G., Domínguez-Andrés, J., Barreiro, L.B. et al. Defining
trained immunity and its role in health and disease. Nat Rev
Immunol 20, 375–388 (2020). https://doi.org/10.1038/
s41577-020-0285-6
Download citation
•  Accepted: 24 January 2020
•  Published: 04 March 2020
•  Version of record: 04 March 2020


•  Issue date: June 2020
•  DOI: https://doi.org/10.1038/s41577-020-0285-6
Share this article
Anyone you share the following link with will be able to read this
content:
Get shareable link
Sorry, a shareable link is not currently available for this article.
Copy shareable link to clipboard
Provided by the Springer Nature SharedIt content-sharing initiative
This article is cited by
•  Extracellular DNA, hyaluronic acid, HIF
pathways, and LncRNAs as predictive biomarkers
of severe COVID-19
○  Evgen Dubrovskyi
○  Tetiana Drevytska
○  Oleksandr Kamyshnyi
Virology Journal (2025)
•  Trained human bone marrow mesenchymal stem
cells restore tissue immuno-microenvironment in
fulminant hepatic failure mice
○  Bingqi Li
○  Xiaofei Zeng
○  Dongyan Shi
Stem Cell Research & Therapy (2025)


•  Targeting mitochondrial transporters and
metabolic reprogramming for disease treatment
○  Mboneye Anselme
○  Huafeng He
○  Shilong Zhong
Journal of Translational Medicine (2025)
•  Innate immune memory in macrophage
differentiation and cardiovascular diseases
○  Yukiteru Nakayama
○  Katsuhito Fujiu
Inflammation and Regeneration (2025)
•  Hematopoietic stem cell state and fate in trained
immunity
○  Weinian Liao
○  Xiaodong Zai
○  Junjie Xu
Cell Communication and Signaling (2025)
 Access through your institution
Buy or subscribe
Associated content
Collection
COVID-19 Watch
Advertisement
[image]


Explore content
•  Research articles
•  Reviews & Analysis
•  News & Comment
•  Videos
•  Current issue
•  Collections
•  Follow us on Facebook
•  Follow us on Twitter
•  Subscribe
•  Sign up for alerts
•  RSS feed
About the journal
•  Aims & Scope
•  Journal Information
•  Editorial policies
•  About the Editors
•  Reviews Cross-Journal Editorial Team
•  Journal Credits
•  Editorial input and checks
•  Editorial Values Statement
•  Journal Metrics
•  Publishing model
•  Calendars
•  Conferences
•  Posters
•  Web Feeds
•  Contact


Publish with us
•  For Authors
•  For Referees
•  Submit manuscript
Search
Search articles by subject, keyword or author
Show results from All journals This journal
Search
Advanced search
Quick links
•  Explore articles by subject
•  Find a job
•  Guide to authors
•  Editorial policies
Nature Reviews Immunology (Nat Rev Immunol)
ISSN 1474-1741 (online)
ISSN 1474-1733 (print)
nature.com sitemap
About Nature Portfolio
•  About us
•  Press releases
•  Press office
•  Contact us
Discover content


•  Journals A-Z
•  Articles by subject
•  protocols.io
•  Nature Index
Publishing policies
•  Nature portfolio policies
•  Open access
Author & Researcher services
•  Reprints & permissions
•  Research data
•  Language editing
•  Scientific editing
•  Nature Masterclasses
•  Research Solutions
Libraries & institutions
•  Librarian service & tools
•  Librarian portal
•  Open research
•  Recommend to library
Advertising & partnerships
•  Advertising
•  Partnerships & Services
•  Media kits
•  Branded content
Professional development
•  Nature Awards
•  Nature Careers
•  Nature Conferences


Regional websites
•  Nature Africa
•  Nature China
•  Nature India
•  Nature Japan
•  Nature Middle East
•  Privacy Policy
•  Use of cookies
•  Your privacy choices/Manage cookies
•  Legal notice
•  Accessibility statement
•  Terms & Conditions
•  Your US state privacy rights
[image]
© 2025 Springer Nature Limited


 Close
[image]
Sign up for the Nature Briefing: Microbiology newsletter — what
matters in microbiology research, free to your inbox weekly.
Email address


Sign up
I agree my information will be processed in accordance with the
Nature and Springer Nature Limited Privacy Policy.
 Close
Get the most important science stories of the day, free in your
inbox. Sign up for Nature Briefing: Microbiology
[image]


